Congressional Democrats rehearse drug pricing attacks

Leaders of some of the world’s leading biopharma companies faced off last week against congressional Democrats – and were soundly defeated.

The two-day hearing on drug pricing convened by the House Oversight and Reform Committee could be considered a rehearsal, or pre-season exhibition game, in advance of hearings and legislation that will come next year. The stakes will be far higher if the Democrats have control over the Senate in 2021...